Eurofins Biopharma Product Testing, Denmark A/S FDA Record
Eurofins Biopharma Product Testing, Denmark A/S has 0 FDA recalls, 5 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Eurofins Biopharma Product Testing, Denmark A/S" is on file.
- Latest inspection
- May 17, 2023 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 5 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Eurofins Biopharma Product Testing, Denmark A/S as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Eurofins Biopharma Product Testing, Denmark A/S yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 17, 2023 | Glostrup, Denmark | Drugs | No Action Indicated (NAI) | 3006272083 |
| Jun 22, 2016 | Glostrup, Denmark | Drugs | Voluntary Action Indicated (VAI) | 3006272083 |
| Dec 14, 2012 | Glostrup, Denmark | Drugs | Voluntary Action Indicated (VAI) | 3006272083 |
| Mar 30, 2012 | Glostrup, Denmark | Drugs | No Action Indicated (NAI) | 3006272083 |
| May 12, 2009 | Glostrup, Denmark | Drugs | Voluntary Action Indicated (VAI) | 3006272083 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006272083 | Glostrup, Denmark | 5 | May 17, 2023 |
Eurofins Biopharma Product Testing, Denmark A/S and the FDA: common questions
Has Eurofins Biopharma Product Testing, Denmark A/S received an FDA warning letter?
No FDA warning letter addressed to the name "Eurofins Biopharma Product Testing, Denmark A/S" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Eurofins Biopharma Product Testing, Denmark A/S received an FDA Form 483?
FDA has not published a Form 483 for "Eurofins Biopharma Product Testing, Denmark A/S" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Eurofins Biopharma Product Testing, Denmark A/S?
The most recent FDA inspection on file ended May 17, 2023 at Glostrup, Denmark and was classified NAI. FDA has 5 inspections of Eurofins Biopharma Product Testing, Denmark A/S on file.
Need more than this page shows? Ask about Eurofins Biopharma Product Testing, Denmark A/S in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.